highly significantp<0.001
This was highly significant for the 5 and 15 mg/kg doses (p<0.001), which increased glucose levels by 24% and 69% compared to controls.
This was highly significant for the 5 and 15 mg/kg doses (p<0.001), which increased glucose levels by 24% and 69% compared to controls.
Similarly, asenapine significantly affected insulin resistance [F (5,43) = 2.59, p<0.05], measured by HOMA-IR, as insulin resistance was significantly reduced with the lowest asenapine dose (0.01 mg/kg) and a strong trend with the next two doses (0.05 and 0.1 mg/kg) ( Table 1 ).